UK-14,304, a potent and selective alpha2-agonist for the characterisation of alpha-adrenoceptor subtypes.
D000316:Adrenergic alpha-Agonists; D000818:Animals; D000068438:Brimonidine Tartrate; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D011651:Pulmonary Artery / Q000187:drug effects; D011810:Quinoxalines / Q000494:pharmacology*; D011817:Rabbits; D011941:Receptors, Adrenergic / Q000145:classification*; D011942:Receptors, Adrenergic, alpha / Q000145:classification*
D000316:Adrenergic alpha-Agonists; D007093:Imidazoles; D011810:Quinoxalines; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D000068438:Brimonidine Tartrate